Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 123.04% is 271% above its 5-year average of -72.10%, near the high end of its 5-year range (-102.21%–123.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 207.37% above its 12-month average of 40.03%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 123.04%.
RETURN ON EQUITY (ROE)
123.04%
RETURN ON EQUITY (ROE) AVG TTM
40.03%
RETURN ON EQUITY (ROE) AVG 3Y
-71.97%
RETURN ON EQUITY (ROE) AVG 5Y
-72.10%
RETURN ON EQUITY (ROE) AVG 10Y
-109.91%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+207.37%
CURRENT VS 3Y AVG
+270.96%
CURRENT VS 5Y AVG
+270.64%
CURRENT VS 10Y AVG
+211.94%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 491 covered companies
CURRENT VS SECTOR MEDIAN
+419.16%
vs the sector median at left
DarioHealth Corp.
Market Cap
$45.37M
Return on Equity (ROE)
123.04%
TTM Avg
40.03%
3Y Avg
-71.97%
5Y Avg
-72.10%
Market Cap
$45.18M
Return on Equity (ROE)
-102.45%
TTM Avg
30.59%
3Y Avg
217.16%
5Y Avg
155.68%
Market Cap
$45.07M
Return on Equity (ROE)
-212.45%
TTM Avg
-170.64%
3Y Avg
-104.70%
5Y Avg
-78.05%
Market Cap
$47.47M
Return on Equity (ROE)
-170.94%
TTM Avg
-132.56%
3Y Avg
-85.15%
5Y Avg
-88.00%
Market Cap
$48.20M
Return on Equity (ROE)
N/A
TTM Avg
-206.96%
3Y Avg
-221.50%
5Y Avg
-349.91%
Market Cap
$42.04M
Return on Equity (ROE)
-66.47%
TTM Avg
-61.13%
3Y Avg
-30.57%
5Y Avg
-24.45%
Market Cap
$42.46M
Return on Equity (ROE)
-260.45%
TTM Avg
-109.97%
3Y Avg
-78.03%
5Y Avg
-56.14%
Market Cap
$48.94M
Return on Equity (ROE)
N/A
TTM Avg
296.81%
3Y Avg
-175.08%
5Y Avg
-1071.79%
Market Cap
$40.28M
Return on Equity (ROE)
-83.03%
TTM Avg
-44.32%
3Y Avg
5.07%
5Y Avg
17.23%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DarioHealth Corp. (DRIO) | $45.37M | 123.04% | 40.03% | -71.97% | -72.10% |
| BioStem Technologies, Inc. (BSEM)vs › | $45.18M | -102.45% | 30.59% | 217.16% | 155.68% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.07M | -212.45% | -170.64% | -104.70% | -78.05% |
| Lite Strategy, Inc. (LITS)vs › | $47.47M | -170.94% | -132.56% | -85.15% | -88.00% |
| Celularity Inc. (CELU)vs › | $48.20M | N/A | -206.96% | -221.50% | -349.91% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.04M | -66.47% | -61.13% | -30.57% | -24.45% |
| CVRx, Inc. (CVRX)vs › | $42.46M | -260.45% | -109.97% | -78.03% | -56.14% |
| Clene Inc. (CLNN)vs › | $48.94M | N/A | 296.81% | -175.08% | -1071.79% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -83.03% | -44.32% | 5.07% | 17.23% |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | -708.48% | 156.13% | 510.26% | 342.91% |
ROE
123.0%
ROA
70.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 123.04% |
| 2026-03-31 | 100.53% |
| 2025-12-31 | 90.89% |
| 2025-09-30 | -45.27% |
| 2025-06-30 | -69.04% |
| 2025-03-31 | -60.79% |
| 2024-12-31 | -59.36% |
| 2024-09-30 | -81.01% |
| 2024-06-30 | -74.65% |
| 2024-03-31 | -68.92% |
| 2023-12-31 | -102.21% |
| 2023-09-30 | -84.90% |
| 2023-06-30 | -73.54% |
| 2023-03-31 | -82.05% |
| 2022-12-31 | -77.74% |
| 2022-09-30 | -80.01% |
| 2022-06-30 | -78.25% |
| 2022-03-31 | -68.06% |
| 2021-12-31 | -89.73% |
| 2021-09-30 | -61.44% |
| 2021-06-30 | -40.87% |
| 2021-03-31 | -30.75% |
| 2020-12-31 | -104.60% |
| 2020-09-30 | -70.28% |
| 2020-06-30 | -170.75% |
| 2020-03-31 | -144.25% |
| 2019-12-31 | -93.87% |
| 2019-09-30 | -474.69% |
| 2019-06-30 | -324.98% |
| 2019-03-31 | -524.19% |
| 2018-12-31 | -199.47% |
| 2018-09-30 | -237.63% |
| 2018-06-30 | -569.31% |
| 2018-03-31 | -297.23% |
| 2017-12-31 | -399.59% |
| 2017-09-30 | -148.26% |
| 2017-06-30 | -198.05% |
| 2017-03-31 | -199.69% |
| 2016-09-30 | -167.91% |
| 2016-06-30 | -142.34% |
| 2016-03-31 | -87.95% |
| 2015-12-31 | -919.31% |
| 2013-06-30 | -801.42% |
